Andrew Obenshain

Andrew Obenshain serves as Chief Executive Officer at bluebird bio. bluebird bio operates in the research sector with approximately 460.0 employees. The company is headquartered in Cambridge, Massachusetts. bluebird bio generates annual revenue of 83807000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 3,781 executive contacts are available in Massachusetts.
• • Our database includes 201,469 c suite-level executives.

Salesforce Amazon SES Mailchimp Mandrill Rackspace MailGun Sendgrid Mimecast Outlook Microsoft Office 365 Microsoft Azure Hosting Drupal Atlassian Cloud Leadfeeder Greenhouse.io Mobile Friendly New Relic Google Tag Manager Bing Ads MouseFlow Google Analytics Remote

gene therapy gene addition sickle cell disease betathalassemia cerebral adrenoleukodystrophy biotechnology life sciences biotechnology: biological products (no diagnostic substances) health care biotechnology research curative therapies lentiviral vector ex-vivo gene therapy one-time treatments beta-thalassemia hemoglobinopathies patient advocacy clinical trials genetic diseases healthcare access blood transfusions iron overload hospital visits disease management chronic conditions genome editing therapeutic potential disease modification clinical research approvals fda-approved therapies patient resources biotech innovation manufacturing sciences quality assurance therapeutic advancements access policies collaborations biopharmaceuticals regulatory compliance medical education transfusion-dependent thalassemia diagnostic testing patient outcomes treatment options research development translational medicine genetic screening comprehensive care medical ethics community engagement clinical practice disease burden biotech partnerships diversity & inclusion corporate giving severe genetic diseases cancer immunotherapy lentiviral vector technology personalized treatment transfusion-dependent beta thalassemia innovative therapies patient-centric care curative treatments rare genetic disorders patient support services research & data leadership inclusivity healthcare equity collaboration innovation integrity excellence transformative healthcare genetic disorders advanced therapies patient well-being genetic causes proprietary technology clinical development patient journey healthcare solutions market focus therapeutic pipeline patient demographics healthcare innovation health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

How can I contact Andrew Obenshain?

Andrew Obenshain's verified email address is available on MessageCEO. They currently work at bluebird bio. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Andrew Obenshain lead?

Andrew Obenshain is Chief Executive Officer at bluebird bio, a company in the research sector with 460.0 employees. The company is based in Cambridge, Massachusetts.

What industry is Andrew Obenshain in?

Andrew Obenshain works in the research industry as Chief Executive Officer at bluebird bio. MessageCEO provides verified contact information for executives across all major industries.

Is Andrew Obenshain's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Andrew Obenshain's profile is kept up-to-date with the latest available information.

Last updated: April 7, 2026